Tag: cancer research

spot_imgspot_img

GSK Launches Tender Offer to Acquire Precision Oncology Innovator Nuvalent, Inc.at $124.00

GSK plc has officially commenced a tender offer to acquire all issued and outstanding shares of Class A and Class B common stock of Nuvalent,...

Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.

Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...

Johnson & Johnson to acquire Firefly Bio to advance novel cancer treatment

Johnson & Johnson  announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a privately held biotechnology company specializing in...